HealthLynked Launches National Initiative to Accelerate Medical Discovery Through Patient Participation and Strategic Pharma Partnerships
HealthLynked (OTCQB: HLYK) has announced a nationwide initiative to accelerate medical research by connecting patients with pharmaceutical and biotech partners through its technology platform. The company, with over 1 million registered members, will roll out research collaboration programs between Q3 2025 and January 2026.
The initiative includes five key partnership tracks: cohort finder & feasibility, recruitment & eConsent, ePROs & RWE generation, signal & safety monitoring, and natural history & rare disease registries. The platform is supported by ARi, an AI healthcare agent built with OpenAI technologies, to analyze patient data and identify trends. Patients can join for free or access premium features for $12/month.
HealthLynked (OTCQB: HLYK) ha annunciato un'iniziativa nazionale per accelerare la ricerca medica collegando i pazienti con partner farmaceutici e biotecnologici tramite la sua piattaforma tecnologica. L'azienda, con oltre 1 milione di membri registrati, lancerà programmi di collaborazione per la ricerca tra il terzo trimestre 2025 e gennaio 2026.
L'iniziativa comprende cinque principali aree di collaborazione: ricerca di coorti e fattibilità, reclutamento e consenso elettronico (eConsent), raccolta di dati ePRO e generazione di RWE, monitoraggio di segnali e sicurezza, e registri di storia naturale e malattie rare. La piattaforma è supportata da ARi, un agente sanitario AI sviluppato con tecnologie OpenAI, che analizza i dati dei pazienti per identificare tendenze. I pazienti possono iscriversi gratuitamente o accedere a funzionalità premium per 12$ al mese.
HealthLynked (OTCQB: HLYK) ha anunciado una iniciativa nacional para acelerar la investigación médica conectando a pacientes con socios farmacéuticos y biotecnológicos a través de su plataforma tecnológica. La empresa, con más de 1 millón de miembros registrados, lanzará programas de colaboración en investigación entre el tercer trimestre de 2025 y enero de 2026.
La iniciativa incluye cinco áreas clave de asociación: búsqueda y viabilidad de cohortes, reclutamiento y consentimiento electrónico (eConsent), ePROs y generación de evidencia del mundo real (RWE), monitoreo de señales y seguridad, y registros de historia natural y enfermedades raras. La plataforma cuenta con el apoyo de ARi, un agente de salud con IA creado con tecnologías de OpenAI, que analiza los datos de los pacientes para identificar tendencias. Los pacientes pueden unirse gratis o acceder a funciones premium por 12$ al mes.
HealthLynked (OTCQB: HLYK)는 기술 플랫폼을 통해 환자와 제약 및 바이오테크 파트너를 연결하여 의학 연구를 가속화하는 전국적인 이니셔티브를 발표했습니다. 100만 명 이상의 등록 회원을 보유한 이 회사는 2025년 3분기부터 2026년 1월 사이에 연구 협력 프로그램을 시작할 예정입니다.
이 이니셔티브는 코호트 찾기 및 타당성, 모집 및 전자 동의(eConsent), 전자 환자 보고 결과(ePRO) 및 실제 증거(RWE) 생성, 신호 및 안전 모니터링, 자연사 및 희귀질환 등록부 등 다섯 가지 주요 파트너십 트랙을 포함합니다. 이 플랫폼은 OpenAI 기술로 구축된 AI 헬스케어 에이전트 ARi의 지원을 받아 환자 데이터를 분석하고 추세를 식별합니다. 환자들은 무료로 가입할 수 있으며, 월 12달러에 프리미엄 기능을 이용할 수 있습니다.
HealthLynked (OTCQB : HLYK) a annoncé une initiative nationale visant à accélérer la recherche médicale en connectant les patients avec des partenaires pharmaceutiques et biotechnologiques via sa plateforme technologique. L'entreprise, qui compte plus de 1 million de membres inscrits, lancera des programmes de collaboration en recherche entre le troisième trimestre 2025 et janvier 2026.
L'initiative comprend cinq axes principaux de partenariat : recherche de cohortes et faisabilité, recrutement et consentement électronique (eConsent), ePROs et génération de données du monde réel (RWE), surveillance des signaux et de la sécurité, ainsi que registres d'histoire naturelle et de maladies rares. La plateforme est soutenue par ARi, un agent de santé IA développé avec les technologies OpenAI, qui analyse les données des patients pour identifier des tendances. Les patients peuvent s'inscrire gratuitement ou accéder à des fonctionnalités premium pour 12 $ par mois.
HealthLynked (OTCQB: HLYK) hat eine landesweite Initiative angekündigt, um die medizinische Forschung zu beschleunigen, indem Patienten über seine Technologieplattform mit pharmazeutischen und biotechnologischen Partnern verbunden werden. Das Unternehmen, das über 1 Million registrierte Mitglieder verfügt, wird zwischen dem dritten Quartal 2025 und Januar 2026 Forschungskooperationsprogramme einführen.
Die Initiative umfasst fünf zentrale Partnerschaftsbereiche: Kohortenfinder & Machbarkeitsstudien, Rekrutierung & elektronische Einwilligung (eConsent), elektronische Patientenergebnisse (ePROs) & Generierung von Real-World-Evidence (RWE), Signal- & Sicherheitsüberwachung sowie Register für natürliche Krankheitsverläufe & seltene Erkrankungen. Die Plattform wird von ARi unterstützt, einem KI-gestützten Gesundheitsagenten, der mit OpenAI-Technologien entwickelt wurde, um Patientendaten zu analysieren und Trends zu erkennen. Patienten können sich kostenlos anmelden oder Premium-Funktionen für 12$ pro Monat nutzen.
- Large established user base of over 1 million registered members
- Multiple revenue streams through pharma partnerships and premium memberships
- Integration of advanced AI technology (ARi) for data analysis
- Structured approach with 5 distinct partnership tracks for research collaboration
- Extended rollout timeline spanning 6 months before full availability
- Trading on OTCQB market rather than major exchanges
- No specific partnership agreements announced yet
- Potential data privacy and security risks handling sensitive health information
HealthLynked Launches National Initiative to Accelerate Medical Discovery Through Patient Participation and Strategic Pharma Partnerships
Founded by physician and healthcare entrepreneur Dr. Michael Dent, who also founded NeoGenomics Laboratories, HealthLynked was created to empower patients and speed the search for cures for life-threatening diseases and cancers. Today's initiative advances that mission by opening clearer, simpler on-ramps for patients to contribute—and by offering research partners structured programs to generate high-quality real-world evidence.
"Most people want to help cure diseases but have very few practical opportunities to do so," said Dr. Dent, CEO of HealthLynked. "By creating a free profile, patients can securely share their health history, opt into studies, and get matched to relevant trials—while our partners gain the real-world evidence they need to move faster from hypothesis to impact."
How Patients Help—and Benefit
Through the free HealthLynked profile, patients can:
- Enter medical history (conditions, medications, procedures, family history) and opt in to research participation.
- Receive personalized notifications—such as trial matches, safety alerts, recall notices, and trend-based insights tied to their health history.
- Contribute patient-reported outcomes (ePROs) and longitudinal updates that help researchers understand disease progression and treatment effectiveness in real-world settings.
All research activity is consent-driven, with data de-identified or aggregated when appropriate, and studies conducted under applicable privacy and ethics requirements (including HIPAA and IRB oversight where required).
Partner Programs for Pharma, Biotech, and Academia
HealthLynked is launching structured collaboration tracks to support the full research lifecycle:
1. Cohort Finder & Feasibility – Rapid identification of consented patient cohorts meeting complex inclusion/exclusion criteria; feasibility assessments across geographies.
2. Recruitment & eConsent – Digital outreach, screening, and IRB-aligned eConsent workflows; optional decentralized trial support.
3. ePROs & RWE Generation – Collection of longitudinal patient-reported outcomes and integration of real-world data to inform endpoints, labeling, and health-economics studies.
4. Signal & Safety Monitoring – Post-marketing surveillance, device and medication safety signal detection, and recall communication to relevant patient segments.
5. Natural History & Rare Disease Registries – Patient-powered registries to understand disease trajectories and support companion diagnostic development.
Six-Month Rollout: These collaboration tracks will be phased in over the next six months as HealthLynked develops and finalizes research partnerships with pharmaceutical sponsors, biotech firms, and academic medical centers—starting in Q3 2025, expanding in Q4 2025, with general availability targeted by January 2026.
ARi: HealthLynked's AI Healthcare Agent
HealthLynked's ARi—built with advanced OpenAI technologies—helps synthesize patient-contributed data to highlight population trends and individual risk signals. ARi aids in feasibility modeling, cohort refinement, and predictive insights that can shorten timelines for study design, trial recruitment, and evidence development. For patients, ARi supports personalized health alerts based on emerging patterns and their own medical history.
A Call to Action
Patients: Join for free, contribute to research, and receive informed insights about your health.
Researchers & Sponsors: Partner with HealthLynked to speed feasibility, recruitment, and RWE generation. Program access will expand throughout the next six months as partnerships are executed.
For those wishing to make an even greater impact, HealthLynked offers premium memberships at
"Imagine if everyone affected by cancer, Alzheimer's, or heart disease could actively participate in finding a cure," added Dr. Dent. "That's the network we're building—a national, and eventually global, research engine powered by patients."
Partnership Opportunities
Organizations interested in joining HealthLynked in its mission to accelerate medical discovery through collaboration and innovation can learn more and connect with the company at www.hlykgroup.com.
About HealthLynked Corp.
HealthLynked Corp. is transforming the future of healthcare through a cloud-based platform that connects patients, physicians, and researchers. HealthLynked provides telemedicine, medical record sharing, discounted prescriptions, and AI-powered health tools to improve outcomes and make care more accessible. With a focus on personalized care and large-scale data insights, HealthLynked empowers individuals to take control of their health while contributing to the advancement of medicine.
To join or learn more, visit www.hlykgroup.com
Download the HealthLynked App:
Forward-Looking Statements
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Such statements are inherently uncertain and may differ materially from actual results. Forward-looking statements reflect management's current expectations and are subject to risks, uncertainties, and assumptions. HealthLynked disclaims any obligation to update these statements except as required by law.
Investor & MediaContact
HealthLynked Corp.
1265 Creekside Parkway, Suite 200
Phone: +1 (800) 928-7144
Email: IR@healthlynked.com
View original content:https://www.prnewswire.com/news-releases/healthlynked-launches-national-initiative-to-accelerate-medical-discovery-through-patient-participation-and-strategic-pharma-partnerships-302521002.html
SOURCE HealthLynked Corp.
FAQ
What is HealthLynked's new national initiative announced on August 5, 2025?
How much does HealthLynked's premium membership cost and what does it include?
When will HealthLynked's (HLYK) research partnership program be fully available?
What are the five partnership tracks offered by HealthLynked for research collaboration?
What is ARi in HealthLynked's platform?
